TI17 is an inhibitor of the thyroid hormone receptor-interacting protein Trip13 and has anticancer activity. TI17 effectively inhibits multiple myeloma (MM) cell proliferation and induces cell cycle arrest and apoptosis. Trip13 is an AAA-ATPase that mediates double-strand break (DSB) repair, TI17 inhibits Trip13 function and increases DNA damage[1].
Molekulargewicht:
374.44
Reinheit:
97
CAS Nummer:
[1005178-02-8]
Formel:
C23H22N2O3
Target-Kategorie:
Apoptosis,Thyroid Hormone Receptor
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten